QUINTA-ANALYTICA
Barbora Skalníková is currently working as an Analytical Chemist at QUINTA-ANALYTICA. Prior to this role, Barbora worked as a Laboratory Analyst at VŠCHT Praha - UCT Prague and as a Laboratory Technician at Vodohospodářská společnost Vrchlice – Maleč, a.s. Barbora holds a Bachelor's and Master's degree in Forensic Analysis from the University of Chemistry and Technology in Prague. Throughout their career, Barbora has been involved in various tasks such as sample preparation, quality control of pharmaceutical products, validation of analytical methods, and measurement of ions in water. Barbora has experience working with a variety of analytical instruments and software, and is skilled in documentation and analysis of scientific data.
QUINTA-ANALYTICA
Quinta is a GCP/GLP/GMP-certified, EMA and FDA-inspected European CRO offering in-house clinical testing, pharmaceutical analysis, CMC and R&D. Quinta specializes in clinical studies, bioanalytics, method development and quality control for both small and large molecules, human and veterinary IMPs as well as generics. We provide unrivaled expertise to worldwide pharmaceutical and biotechnological clients across the entire pharma spectrum. Quinta is part of the Conscio group with headquarters in Munich, Germany, laboratories in Czechia, Austria, Slovakia, Germany and offices in the USA. Our main service areas include: 1) Clinical Testing: With 2 in-house clinical units providing BE/BA/PK studies, with capacity for 60+40 beds. 2) Bioanalytical Testing: GLP/GCP solutions for preclinical & clinical studies, small & large molecules, BE/BA/PK. 3) Research & Development: Analytical R&D, impurities, extractables & leachables, degradation, trace studies. 4) Pharmaceutical Quality Control: GMP quality control, batch testing, stabilities, HAPIs, inhalation, API sourcing. 5) Microbiology: GMP sterile & non-sterile testing, microbial/water analyses, endotoxins, antibiotics & vitamins. 6) Biopharmaceutical Quality Control: GLP/GMP bioanalysis, CMC, characterizations of peptide & protein IMPs, biosimilars. Quinta was founded in 1997 and has been successfully inspected by FDA more than 10 times. Quinta is headquartered in Prague, Czech Republic.